肿瘤研究与临床
腫瘤研究與臨床
종류연구여림상
CANCER RESEARCH AND CLINIC
2013年
3期
148-151,155
,共5页
曹磊%力超%张红%杨映红%陈强%叶韵斌
曹磊%力超%張紅%楊映紅%陳彊%葉韻斌
조뢰%력초%장홍%양영홍%진강%협운빈
头颈部肿瘤%癌,鳞状细胞%肿瘤干细胞%CD133-2%CD24%CD44S
頭頸部腫瘤%癌,鱗狀細胞%腫瘤榦細胞%CD133-2%CD24%CD44S
두경부종류%암,린상세포%종류간세포%CD133-2%CD24%CD44S
Head and neck neoplasms%Carcinoma,squamous cell%Neoplastic stem cells%CD133-2%CD24%CD44s
目的 探讨肿瘤干细胞标志物CD133-2、CD24、CD44S在头颈部鳞状细胞癌(HNSCC)组织中的表达情况及其临床意义.方法 采用免疫组织化学SP法,分别检测83例HNSCC患者癌组织、46例癌旁正常鳞状上皮组织中CD133-2、CD24、CD4s的表达,分析表达情况及与临床病理特征的关系.结果 CD133-2在癌组织、癌旁正常鳞状上皮组织中表达率分别为9.64 %(8/83) 、21.74 %(10/46),CD24分别为90.36%(75/83)、45.65%(21/46),差异均有统计学意义(x2值分别为15.040、5.818,均P<0.05);CD44S在癌组织、癌旁正常组织中均表达,但其染色评分差异有统计学意义(Z=-4.262,P< 0.05).在癌组织中,CD133-2的表达与组织的分化程度呈负相关(x2=7.246,P< 0.05),CD24和CD44S的表达均与组织的分化程度呈正相关(x2值分别为9.005、44.765,均P<0.05),CD44S的表达与T分期呈负相关(x2=4.650,P<0.05).结论 CD24、CD44S在HNSCC中的表达随着肿瘤细胞的分化程度增高而增高,能否作为HNSCC的肿瘤干细胞标志物尚需进一步研究;CD133-2表达随肿瘤细胞的分化程度增高而呈下调趋势,可以作为肿瘤干细胞的标志物,并可能与肿瘤的进展、临床预后相关.
目的 探討腫瘤榦細胞標誌物CD133-2、CD24、CD44S在頭頸部鱗狀細胞癌(HNSCC)組織中的錶達情況及其臨床意義.方法 採用免疫組織化學SP法,分彆檢測83例HNSCC患者癌組織、46例癌徬正常鱗狀上皮組織中CD133-2、CD24、CD4s的錶達,分析錶達情況及與臨床病理特徵的關繫.結果 CD133-2在癌組織、癌徬正常鱗狀上皮組織中錶達率分彆為9.64 %(8/83) 、21.74 %(10/46),CD24分彆為90.36%(75/83)、45.65%(21/46),差異均有統計學意義(x2值分彆為15.040、5.818,均P<0.05);CD44S在癌組織、癌徬正常組織中均錶達,但其染色評分差異有統計學意義(Z=-4.262,P< 0.05).在癌組織中,CD133-2的錶達與組織的分化程度呈負相關(x2=7.246,P< 0.05),CD24和CD44S的錶達均與組織的分化程度呈正相關(x2值分彆為9.005、44.765,均P<0.05),CD44S的錶達與T分期呈負相關(x2=4.650,P<0.05).結論 CD24、CD44S在HNSCC中的錶達隨著腫瘤細胞的分化程度增高而增高,能否作為HNSCC的腫瘤榦細胞標誌物尚需進一步研究;CD133-2錶達隨腫瘤細胞的分化程度增高而呈下調趨勢,可以作為腫瘤榦細胞的標誌物,併可能與腫瘤的進展、臨床預後相關.
목적 탐토종류간세포표지물CD133-2、CD24、CD44S재두경부린상세포암(HNSCC)조직중적표체정황급기림상의의.방법 채용면역조직화학SP법,분별검측83례HNSCC환자암조직、46례암방정상린상상피조직중CD133-2、CD24、CD4s적표체,분석표체정황급여림상병리특정적관계.결과 CD133-2재암조직、암방정상린상상피조직중표체솔분별위9.64 %(8/83) 、21.74 %(10/46),CD24분별위90.36%(75/83)、45.65%(21/46),차이균유통계학의의(x2치분별위15.040、5.818,균P<0.05);CD44S재암조직、암방정상조직중균표체,단기염색평분차이유통계학의의(Z=-4.262,P< 0.05).재암조직중,CD133-2적표체여조직적분화정도정부상관(x2=7.246,P< 0.05),CD24화CD44S적표체균여조직적분화정도정정상관(x2치분별위9.005、44.765,균P<0.05),CD44S적표체여T분기정부상관(x2=4.650,P<0.05).결론 CD24、CD44S재HNSCC중적표체수착종류세포적분화정도증고이증고,능부작위HNSCC적종류간세포표지물상수진일보연구;CD133-2표체수종류세포적분화정도증고이정하조추세,가이작위종류간세포적표지물,병가능여종류적진전、림상예후상관.
Objective To explore the expressions and significances of the tumor stem cell markers CD133-2,CD24 and CD44s in head and neck squamous cell carcinoma (HNSCC) tissues and their association with the clinical pathologic characteristics.Methods Expressions of CD133-2,CD24 and CD44s were analyzed by immunohistochemistry (SP) in 83 cases of primary HNSCC tissues and 46 cases of normal epithelia.Clinicopathological indexes were assessed.Results In primary HNSCC tissues and normal epithelia,the expression rates of CD133-2 and CD24 were 9.64 % (8/83),21.74 % (10/46) and 90.36 % (75/83),46.67 % (21/46)respectively,which had statistically significances (x2 =15.040,5.818,P < 0.05).CD44s expression was detected in primary HNSCC tissues and normal epithelia,but their staining scores had statistical significance (Z =-4.262,P < 0.05).In primary HNSCC tissues,the expression of CD133-2 had negative correlation with differentiation degree (x2 =7.246,P < 0.05),but CD24 and CD44s had positive correlation with differentiation degree (x2 =9.005,44.765,P < 0.05).In addition,the expression of CD44s in primary HNSCC tissues had negative correlation with T classification (x2 =4.650,P < 0.05).Conclusion The expressions of CD24 and CD44s in primary HNSCC tissues are highly up-regulated with tumor cells differentiation,and further research needs to be performed to discover whether or not CD24 and CD44s could be the markers of tumor stem cells of HNSCC.The expression of CD133-2 in primary HNSCC tissues is highly down-regulated with tumor cell differentiation.As one of the tumor stem cell markers of HNSCC,CD133-2 may play an important role in the development and clinical outcomes of tumor.